IP Library Granted Patent US 11,242,531
Granted Patent B2
US 11,242,531 · App. 16/483,392 · Granted Feb 8, 2022

Compositions and methods for the treatment of hypercholesterolemia

Inventors: Kevin V. Morris (Sierra Madre, CA); Roslyn Ray (Monrovia, CA)
Assignee: CITY OF HOPE
C12N15/1138A61K31/713A61P3/06C12N2310/113C12N2310/14C12N2310/315C12N2310/321C12N2310/3341C12N2310/351C12N2310/3515C12N2320/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,242,531
App. No.
16/483,392
Granted
Feb 8, 2022
Kind
B2
Abstract

Provided herein are, inter alia, compositions and methods for the treatment of hypercholesterolemia. The compositions include double-stranded and single-stranded RNAs capable of repressing IncRNA and concomitantly increasing LDLR activation. The compositions are useful for activating LDLR in liver cells.

Claims (5)

1. A method of treating hypercholesterolemia, said method comprising administering to a subject in need thereof an effective amount of a ribonucleic acid compound,

said ribonucleic acid compound comprising an RNA sequence having at least 95% sequence identity to the complement of at least 15 consecutive nucleotides of nucleotides 1-147 of SEQ ID NO:1, wherein said RNA sequence is capable of hybridizing to nucleotides 27-47 of SEQ ID NO:1; or

said ribonucleic acid compound comprising an RNA sequence having at least 95% sequence identity to the complement of at least 15 consecutive nucleotides of nucleotides 541-631 of SEQ ID NO:2, wherein said RNA sequence is capable of hybridizing to nucleotides 582-602 of SEQ ID NO:2.

2. The method of claim 1 , wherein said RNA sequence is SEQ ID NO:12.

3. The method of claim 1 , wherein said RNA sequence is SEQ ID NO:18.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 8, 2023
From: BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 064522/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2019
From: MORRIS, KEVIN V.; RAY, ROSLYN
To: CITY OF HOPE
Reel/Frame 050407/0606 →
Continuity (2)
Provisional Application 62454629 · Feb 3, 2017
Related Publication 20200040343A1 · Feb 6, 2020